Loading...

HEXO Corp.

HEXO•NASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$0.71
$0.02(2.45%)

HEXO Corp. (HEXO) Stock Overview

Explore HEXO Corp.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B

Score: 62.2/100

Key Financials

Market Cap31.2M
P/E Ratio-0.03
EPS (TTM)$-2.77
ROE-2.06%
Fundamental Analysis

AI Price Forecasts

1 WeekN/A
1 MonthN/A
3 MonthsN/A
1 Year Target$0.35

HEXO Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of HEXO Corp. (HEXO) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $0.35.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.03 and a market capitalization of 31.2M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;